The antiepileptic drug mephobarbital is not transported by P-glycoprotein or multidrug resistance protein 1 at the blood–brain barrier: A positron emission tomography study

This publication has 31 references indexed in Scilit:

• In vitro concentration dependent transport of phenytoin and phenobarbital, but not ethosuximide, by human P-glycoprotein
  Life Sciences, 2010
• Dose-response assessment of tariquidar and elacridar and regional quantification of P-glycoprotein inhibition at the rat blood-brain barrier using (R)-[11C]verapamil PET
  European Journal of Nuclear Medicine and Molecular Imaging, 2009
• A Pilot Study to Assess the Efficacy of Tariquidar to Inhibit P-glycoprotein at the Human Blood–Brain Barrier with (R)-¹¹C-Verapamil and PET
  Journal of Nuclear Medicine, 2009
• Imaging the Function of P-Glycoprotein With Radiotracers: Pharmacokinetics and In Vivo Applications
  Clinical Pharmacology & Therapeutics, 2009
• Several major antiepileptic drugs are substrates for human P-glycoprotein
  Neuropharmacology, 2008
• On The Rate and Extent of Drug Delivery to the Brain
  Pharmaceutical Research, 2007
• Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein
  Neuropharmacology, 2007
• Molecular and cellular mechanisms of pharmacoresistance in epilepsy
  Brain, 2005
• A simple synthesis of [11C]methyl triflate
  International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1992
• The synthesis of some 11C-labelled antiepileptic drugs with potential utility as radiopharmaceuticals: Hydantoins and barbiturates
  The International Journal of Applied Radiation and Isotopes, 1981